Predict your next investment

Corporation

See what CB Insights has to offer

About Ipca Pharmaceuticals

Ipca Pharmaceuticals is a subsidiary of Ipca Laboratories.

Ipca Pharmaceuticals Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Ipca Pharmaceuticals Acquisitions

1 Acquisition

Ipca Pharmaceuticals acquired 1 company. Their latest acquisition was Bayshore Pharmaceuticals on October 03, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/3/2018

$991

Corporate Majority

1

Date

10/3/2018

Investment Stage

Companies

Valuation

$991

Total Funding

Note

Corporate Majority

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.